Status:
UNKNOWN
Ablation Index Guided High Power Ablation for Pulmonary Vein Isolation in Patients With Atrial Fibrillation
Lead Sponsor:
Seoul National University Hospital
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
The investigators will compare the ablation time during pulmonary vein isolation of Ablation Index-guided high power ablation with those with conventional ablation. Ablation time of conventional grou...
Detailed Description
Ablation Index guided high power ablation will be performed in 70 patients with atrial fibrillation with prospectively and consecutively. A contact force-sensing catheter will be used. Ablation will b...
Eligibility Criteria
Inclusion
- Patients with symptomatic paroxysmal or persistent AF who failed anti-arrhythmic agents
Exclusion
- Patients who had previous ablation for AF
- Patients with left atrial diameter more than 50 mm
- Inability or unwillingness to receive oral anticoagulation with a vitamin K antagonist (VKA) or non-VKA (NOAC) agent
- Known severe left ventricular systolic dysfunction (ejection fraction \<35%)
- Pregnancy
Key Trial Info
Start Date :
October 30 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2020
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04379557
Start Date
October 30 2018
End Date
December 30 2020
Last Update
May 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National university Hostpital
Seoul, Jongno-gu, South Korea, 03080